CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 14 filers reported holding CYCLO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $142,780 | -10.5% | 100,507 | +0.1% | 0.00% | – |
| Q2 2023 | $159,616 | +263.2% | 100,388 | +92.1% | 0.00% | – |
| Q1 2023 | $43,944 | +59283.8% | 52,253 | 0.0% | 0.00% | – |
| Q4 2022 | $74 | -99.9% | 52,253 | +8.1% | 0.00% | – |
| Q3 2022 | $93,000 | -3.1% | 48,316 | 0.0% | 0.00% | – |
| Q2 2022 | $96,000 | -37.3% | 48,316 | 0.0% | 0.00% | – |
| Q1 2022 | $153,000 | -12.1% | 48,316 | +3.1% | 0.00% | – |
| Q4 2021 | $174,000 | -49.9% | 46,848 | -9.0% | 0.00% | – |
| Q3 2021 | $347,000 | -20.2% | 51,454 | +20.8% | 0.00% | – |
| Q2 2021 | $435,000 | +191.9% | 42,577 | +133.2% | 0.00% | – |
| Q1 2021 | $149,000 | – | 18,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 75,787 | $240,000 | 0.00% |
| ROYAL BANK OF CANADA | 746 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 255,065 | $808,000 | 0.00% |
| UBS Group AG | 2,291 | $7,000 | 0.00% |
| IFP Advisors, Inc | 26 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,047 | $6,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 48,316 | $153,000 | 0.00% |
| STATE STREET CORP | 28,300 | $90,000 | 0.00% |
| CITIGROUP INC | 1,232 | $4,000 | 0.00% |